Table 1 |
||||
|
Primer sets and conditions for amplification of human KIT exons. Forward and reverse primers flanking each of the 21 exons are shown. The size of each exon-coding region, the size of each PCR product generated by each set of primers, and the respective annealing temperatures are indicated. Sequences marked by a * are derived from Spritz et al..[28] |
||||
|
Exon No |
Exon # Size (bp) |
Primers |
PCR product Size (bp) |
Annealing Tm(°C) |
|
|
||||
|
Forward Reverse |
||||
|
|
||||
|
1 |
88(67) |
5'GGACCAGAGCTCGGATC3' / 3'AGTCCTCTCTCCGGATG5' |
198 |
62 |
|
2 |
270 |
5'CTCAGTATTGGAAGAAGTGC3' / 3'TATCTATGGCTCAGTCATCC5' |
438 |
55 |
|
3 |
282 |
5'GCTTCTATAGATCCTGCC3' / 3'GATCAACGAGAAGAGAAGTC5' * |
367 |
55 |
|
4 |
137 |
5'TGTACACATTTGAGGAGAAA3' * / 3'CTGACAGACGCACTAGTCG5' * |
330 |
55 |
|
5 |
169 |
5'TGGAGAAGTTAATTGCTGCT3' * / 3'TGTGCTTTCATTGCAAGAGG5' |
435 |
55 |
|
6 |
190 |
5'TTGTAATTCCAAGATGAGG3' * / 3'TACTAGGATGAGGACATAGG5' |
422 |
55 |
|
7 |
116 |
5'TATGTGTGTGCGTGTTTATG3' * / 3'CAAGTTGAGTCCTTGCAGCTG5' * |
372 |
62 |
|
8 |
115 |
5'CTCCTTGGTTCAGATTCTGC3' / 3'GTGAATTGCAGTCCTTCC5' |
321 |
55 |
|
9 |
194 |
5'TATGCCACATCCCAAGTG3' / 3'GGTGTGATGCATGTATTACC5' |
390 |
55 |
|
10 |
107 |
5'ACATAGCTTTGCATCCTGC3' / 3'ATTGTCTCAGTCATTAGAGCAC5' * |
280 |
55 |
|
11 |
127 |
5'GAGTGCTCTAATGACTGAG3' / 3'CCACTGGAGTTCCTTAAAG5' |
266 |
56 |
|
12 |
105 |
5'ATGGTCCTTCAATTCCACC3' / 3'TTCTGTCAAATGGGCACTC5' |
270 |
55 |
|
13 |
111 |
5'GACATCAGTTTGCCAGTTG3' / 3'GCAAGAGAGAACAACAG5' |
296 |
58 |
|
14 |
151 |
5'GACTAAGTAGTCTGATCC3' / 3'ACCCCATGAACTGCCTGTC5' * |
327 |
55 |
|
15 |
92 |
5'TAGAGCATGACCCATGAG3' / 3'ACCCACTTGCAACCCTAACT5' * |
325 |
60 |
|
16 |
128 |
5'GGTATGTCATTGCCACTG3' / 3'GGCTCTAAAATGCTCTGTTCT5' * |
296 |
55 |
|
17 |
123 |
5'GTGAACATCATTCAAGGCG3' / 3'TTACATTATGAAAGTCACAGG5' * |
390 |
55 |
|
18 |
112 |
5'CACATTTCAGCAACAGC3' / 3'CCTTCCTTGATCATCTTGT5' * |
382 |
53 |
|
19 |
100 |
5'CTCAGAGCATCTTCTTGAAG3' / 3'ACATCTGGGTTTCTGTCTC5' |
252 |
58 |
|
20 |
106 |
5'CCATATGTCCAGTTGCATAG3' / 3'TACCTGAAGCCCAATTTGC5' |
257 |
60 |
|
21 |
2407(129) |
5'TGGCCACAAAGTTCTTGG3' / 3'TATCCTGGAGTTGGATGC5' |
369 |
55 |
|
|
||||
|
Shibanuma et al. BMC Women's Health 2002 2:8 doi:10.1186/1472-6874-2-8 |
||||